What does DOMICAPHARMA do?

DOMICAPHARMA is a pharmacy in Sint-Laureins. Private Limited, started on 6 February 2023, 1 establishment.

What is the address of DOMICAPHARMA?

The registered office of DOMICAPHARMA is located at Stee(WAT) 31, 9988 Sint-Laureins.

Is DOMICAPHARMA still active?

Yes. According to the CBE (30 October 2026) DOMICAPHARMA is active, legal situation “Normale toestand”, started on 6 February 2023.

Is DOMICAPHARMA registered on Peppol?

Yes, DOMICAPHARMA is registered on the Peppol network with ID 0208:0798126193.

What is the enterprise number of DOMICAPHARMA?

The enterprise number of DOMICAPHARMA is BE0798126193.

When was DOMICAPHARMA founded?

DOMICAPHARMA was founded on 6 February 2023.

Who are the directors of DOMICAPHARMA?

According to the 2025 annual accounts, the directors of DOMICAPHARMA are: Dokriphar.

Is DOMICAPHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 February 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOMICAPHARMA make in 2025?

DOMICAPHARMA posted a profit after taxes of € 46,457 in financial year 2025.

What is the revenue of DOMICAPHARMA?

As a small company, DOMICAPHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 205,194.

How much does an employee at DOMICAPHARMA earn?

The average wage cost per full-time employee at DOMICAPHARMA was € 58,900 in 2024: staff costs of € 106,000 for 1.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

Does DOMICAPHARMA have a website?

Yes, DOMICAPHARMA has a website at apotheeknoord.be.

DOMICAPHARMA (Private Limited) - Sint-Laureins

Dossier DOMICAPHARMA, printed on 30 October 2026 from databakkes.be/en/0798126193/domicapharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOMICAPHARMA from Sint-Laureins, company number BE0798126193, closed financial year 2025 with a result of € 46,457 after tax. For that financial year DOMICAPHARMA recorded a gross margin of € 205,194 and equity of € 426,491. Compared with financial year 2024, the result moved from € 59,928 to € 46,457. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.

What it is worth Growing

€ 426,491

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 46,457

▼ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 314,844

▲ 104% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 45,000 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 136,402

▲ 29% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,668

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 125,847

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 13,997

▲ 113% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 236,881 Gross margin 2023: € 236,881 First fiscal year in the series	€ 193,590 Gross margin 2024: € 193,590 ▼ 18% vs 2023 (€ 236,881) Unfavourable step	€ 205,194 Gross margin 2025: € 205,194 ▲ 6% vs 2024 (€ 193,590) Favourable step	▲ 6%
Profit after taxes	€ 93,960 Profit after taxes 2023: € 93,960 First fiscal year in the series	€ 59,928 Profit after taxes 2024: € 59,928 ▼ 36% vs 2023 (€ 93,960) Unfavourable step	€ 46,457 Profit after taxes 2025: € 46,457 ▼ 22% vs 2024 (€ 59,928) Unfavourable step	▼ 22%
Equity	€ 420,106 Equity 2023: € 420,106 First fiscal year in the series	€ 425,034 Equity 2024: € 425,034 ▲ 1% vs 2023 (€ 420,106) Favourable step	€ 426,491 Equity 2025: € 426,491 Unchanged (€ 425,034) Favourable step
Total debts	€ 211,426 Total debts 2023: € 211,426 First fiscal year in the series	€ 206,446 Total debts 2024: € 206,446 ▼ 2% vs 2023 (€ 211,426) Favourable step	€ 263,756 Total debts 2025: € 263,756 ▲ 28% vs 2024 (€ 206,446) Unfavourable step	▲ 28%
Cash	€ 123,293 Cash 2023: € 123,293 First fiscal year in the series	€ 154,156 Cash 2024: € 154,156 ▲ 25% vs 2023 (€ 123,293) Favourable step	€ 314,844 Cash 2025: € 314,844 ▲ 104% vs 2024 (€ 154,156) Favourable step	▲ 104%
Retained profit	€ 409,350 Retained profit 2023: € 409,350 First fiscal year in the series	€ 414,279 Retained profit 2024: € 414,279 ▲ 1% vs 2023 (€ 409,350) Favourable step	€ 415,736 Retained profit 2025: € 415,736 Unchanged (€ 414,279) Favourable step
Dividend	€ 90,000 Dividend 2023: € 90,000 First fiscal year in the series	€ 55,000 Dividend 2024: € 55,000 ▼ 39% vs 2023 (€ 90,000) Unchanged	€ 45,000 Dividend 2025: € 45,000 ▼ 18% vs 2024 (€ 55,000) Unchanged	▼ 18%
Balance sheet total	€ 631,531 Balance sheet total 2023: € 631,531 First fiscal year in the series	€ 631,480 Balance sheet total 2024: € 631,480 Unchanged (€ 631,531) Unchanged	€ 690,248 Balance sheet total 2025: € 690,248 ▲ 9% vs 2024 (€ 631,480) Unchanged	▲ 9%
Employees (FTE)	1.8 Employees (FTE) 2023: 1.8 First fiscal year in the series	1.8 Employees (FTE) 2024: 1.8 Unchanged (1.8) Unchanged	-

Key figures of DOMICAPHARMA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DOMICAPHARMA?

What happened at DOMICAPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 30, 2026 New annual accounts for financial year 2025: profit of € 46,457 (▼ 22% vs 2024). Source: NBB ↗
Feb 6, 2023 New establishment in Sint-Laureins. KBO
Feb 6, 2023 Start of the company according to the CBE. KBO

In short

From € 93,960 profit in 2023 to € 46,457 profit in 2025.

Paid € 6,049 in corporate taxes since 2023.

Best year ever: 2023, with € 93,960 profit.

On average € 107,600 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Dokriphar

DOMICAPHARMA

CASSIPHARMA

3-FOLIA

Behind DOMICAPHARMA is Dokriphar. Dokriphar is also behind CASSIPHARMA and 3-FOLIA.

Directors

According to the 2025 annual accounts

Dokriphar

Director · represented by Dominiek SIMOENS

Also active at: CASSIPHARMA, 3-FOLIA

Establishments

Establishment units

Physical locations of this company

Registered office

Stee(WAT) 31

9988 Sint-Laureins

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeknoord.be

Technologies

ApacheBootstrapDiviElementorFont AwesomeGoogle FontsOwl CarouselPHPSwiperWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

A2HOSTING - A2 Hosting, Inc., US

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number: 0798.126.193
VAT number: BE 0798.126.193
Registered office: Stee(WAT) 31, 9988 Sint-Laureins
Names & denominations: DOMICAPHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 February 2023
Peppol: Active · Active since 7 Oct 2025
Contact: apotheeknoord.be 09/379 88 60
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗